Aseptically Manipulated or Terminally Sterile Medicinal Products

A Contract Award Notice
by PENINSULA PURCHASING & SUPPLY ALLIANCE

Source
Find a Tender
Type
Contract (Goods)
Duration
not specified
Value
£170K-£25M
Sector
HEALTH
Published
20 Aug 2024
Delivery
not specified
Deadline
n/a

Concepts

Location

South West England: Bristol, Devon, Cornwall, Gloucestershire, Somerset & Wiltshire

Geochart for 1 buyers and 5 suppliers

1 buyer

2 suppliers

Description

The supply of aseptically manipulated or terminally sterile products to NHS Trusts within the boundaries of the Peninsula Purchasing and Supply Alliance (PPSA). Products include national dose-banded cytotoxic and non-cytotoxic batch and patient specific medicines in ready-to-use infusion bags and pre-filled syringes. This procurement is being managed by the Peninsula Purchasing and Supply Alliance (hereafter referred to as the PPSA) on behalf of the Royal Devon University Healthcare NHS Foundation Trust (hereafter referred to as the Organisation) acting for itself and for Gloucestershire Hospitals NHS Trust, Great Western Hospitals NHS Foundation Trust, Royal Cornwall Hospitals NHS Trust, Salisbury NHS Foundation Trust, Somerset NHS Foundation Trust, Torbay & South Devon NHS Foundation Trust, University Hospitals Plymouth NHS Trust, North Bristol NHS Trust, University Hospitals Bristol & Weston NHS Foundation Trust and the Royal United Hospital Bath NHS Foundation Trust.

Lot Division

1 Aseptically prepared products

Supply of Cyclophosphamide, Doxorubicin & Pembrolizumab compounded ready-to-use batch and patient-specific products. Additional information: The invitation to tender (ITT) documents and additional information is available from CTM e-procurement portal at https://uk.eu-supply.com Tenders or requests to participate must be submitted electronically via the CTM e-procurement portal at https://uk.eu-supply.com If not already registered on CTM eu-supply.com you will need to register as a supplier to express interest.

Award Criteria
QA Processes & Service 30%
Social Value 10%
Stability 15%
price 45%
2 Aseptically prepared products

Supply of Carboplatin, Epirubicin, Nivolumab & Paclitaxel.

Award Criteria
QA Processes & Service 30%
Social Value 10%
Stability 15%
price 45%
3 Aseptically Prepared Products

Supply of Atezolizumab (Tecentriq®), Bortezomib Subcut, Docetaxel, Fluorouracil, Oxaliplatin & Vincristine.

Award Criteria
QA Processes & Service 30%
Social Value 10%
Stability 15%
price 45%
4 Aseptically Prepared Products

Supply of Cytarabine, Daunorubicin, Ganciclovir & Vinblastine.

Award Criteria
QA Processes & Service 30%
Social Value 10%
Stability 15%
price 45%
5 Aseptically Prepared Products

Supply of Cabazitaxel

Award Criteria
QA Processes & Service 30
Social Value 10
Stability 15
price 45

Award Detail

1 Quantum Pharmaceutical (Burnopfield)
  • Lot 1
  • Reference: 026414-2024-1-1
  • Value: £25,000,000
2 Qualasept (Corsham)
  • Lot 2
  • Reference: 026414-2024-2-2
  • Value: £13,000,000
3 Quantum Pharmaceutical (Burnopfield)
  • Lot 3
  • Reference: 026414-2024-3-3
  • Value: £5,000,000
4 Qualasept (Corsham)
  • Lot 4a
  • Reference: 026414-2024-4a-4
  • Value: £450,000
5 Quantum Pharmaceutical (Burnopfield)
  • Lot 4b
  • Reference: 026414-2024-lot 4b-5
  • Value: £170,000

CPV Codes

  • 33600000 - Pharmaceutical products
  • 33690000 - Various medicinal products
  • 33692100 - Infusion solutions
  • 33692500 - Injectable solutions
  • 33692510 - Intravenous fluids
  • 33693100 - Toxins

Indicators

  • Options are available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The following Trusts may join any Contract(s) awarded from the Tender at any time during the Contract Period including Dorset County Hospital NHS Foundation Trust, Jersey General Hospital, Princess Elizabeth Hospital, Guernsey and University Hospitals Dorset NHS Foundation Trust.

Reference

Domains